Inoue T, Inoue Y, Nakamura T, Yoshida A, Inoue Y, Tano Y, Shimomura Y, Fujisawa Y, Aono A, Hayashi K
Department of Ophthalmology, Osaka University Medical School, 2-2 Yamadaoka, Suita 565-0871, Japan.
Nippon Ganka Gakkai Zasshi. 2001 Apr;105(4):223-9.
To evaluate the effect of vaccination with fusion protein(gD-IL-2) consisting of herpes simplex type1(HSV-1) glycoprotein D(gD) and human interleukin-2(IL-2), and the effect of plasmid DNA vaccine encoding gD-IL-2 against murine herpetic keratitis.
Plasmid containing gD-IL-2(pHDL-neol) was constructed, and gD-IL-2 peptide was purified. BALB/c mice were injected twice hypodermally or subconjunctivally with 1 microgram/0.1 ml of gD-IL-2 peptide, or twice subconjunctivally with 90 micrograms/0.05 ml of gD-IL-2 plasmid DNA. Neutralizing antibody titer and delayed-type hypersensitivity (DTH) against HSV-1 were measured. Immunized mice were challenged with CHR3 strain of HSV-1 via the cornea. The clinical picture of epithelial and stromal keratitis was scored.
Stromal keratitis was inhibited in gD-IL-2 peptide- or gD-IL-2 DNA-immunized mice, but epithelial keratitis was not. It was confirmed that plasmid gD-IL-2 elicited significant serum virus neutralizing titer and DTH response.
Vaccination with gD-IL-2 was effective against herpetic keratitis.
评估由单纯疱疹病毒1型(HSV-1)糖蛋白D(gD)和人白细胞介素-2(IL-2)组成的融合蛋白(gD-IL-2)疫苗接种效果,以及编码gD-IL-2的质粒DNA疫苗对小鼠疱疹性角膜炎的作用。
构建含gD-IL-2的质粒(pHDL-neol),纯化gD-IL-2肽。将BALB/c小鼠皮下或结膜下注射两次1微克/0.1毫升的gD-IL-2肽,或结膜下注射两次90微克/0.05毫升的gD-IL-2质粒DNA。检测针对HSV-1的中和抗体滴度和迟发型超敏反应(DTH)。经角膜用HSV-1的CHR3株攻击免疫小鼠。对上皮性和基质性角膜炎的临床表现进行评分。
gD-IL-2肽或gD-IL-2 DNA免疫的小鼠基质性角膜炎受到抑制,但上皮性角膜炎未受抑制。证实质粒gD-IL-2可诱导显著的血清病毒中和滴度和DTH反应。
gD-IL-2疫苗接种对疱疹性角膜炎有效。